Researchers at VCU Massey Comprehensive Cancer Center are leading an international study that advances the understanding of ...

UC San Francisco Chancellor emeritus J. Michael Bishop, MD, a pioneering microbiologist who shared the 1989 Nobel Prize in ...

A multinational research team has revealed how a tryptophan-rich allosteric communication network regulates receptor dynamics ...

Researchers discovered a compound in python blood, para-tyramine-O-sulfate (pTOS), that suppresses appetite and promotes ...

Iron metabolism represents a key area of cancer research, as iron is crucial for cellular proliferation and many metabolic processes. Tumors often exhibit ...

Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets while developing a diverse pipeline of novel, ...

Boundless Bio (Nasdaq: BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable oncogene ...

ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., March 17, 2026 (GLOBE NEWSWIRE) -- Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a novel class of ...

Prelude Therapeutics Incorporated (Nasdaq: PRLD), a precision oncology company, today announced that a poster with ...

Boundless Bio (Nasdaq: BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable ...

Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, ...

Chronos‑PD shows that biological changes associated with Parkinson’s disease (PD) can emerge up to 12 years before ...